Novavax Coronavirus Vaccine Induces Immune Response in Early Study, Shares Jump
The company said it could start a large pivotal Phase III trial as soon as late September, and on a conference call added that it could produce 1 billion to 2 billion doses of the vaccine in 2021.https://ift.tt/2CYnouO
https://ift.tt/2Pm13dI
No comments
If you have any doubt please let me know